| Outcome Measures: |
Primary: NT-pro-BNP, Change from baseline to 4 weeks in NT-pro-BNP, 4 weeks|Total peripheral resistance index, The change from baseline to 4 weeks in total peripheral resistance index will be measured using Non-Invasive Cardiac Output Monitoring (Cheetah), 4 weeks | Secondary: BNP, Change from baseline to 4 weeks in BNP, 4 weeks|Fatigue, The change in fatigue from baseline to 4 weeks, measured by the Functional Assessment of Chronic Illness Therapy - Fatigue, a validated measure of patient-reported fatigue, 4 weeks|Depression, The change in depressive symptoms from baseline to 4 weeks, measured by the Quick Inventory of Depressive Symptomatology, a validated measure of patient-reported depression, 4 weeks|Quality of Life - Kidney Disease Quality of Life (KDQOL), The change in quality of life from baseline to 4 weeks, measured by the KDQOL, a validated measure of patient-reported quality of life, 4 weeks|Hospitalizations, Hospitalizations as quantified by review of the medical record and telephone contact with the participant, 6 months|Systolic blood pressure, The change in systolic blood pressure from baseline to 4 weeks, 4 weeks|Diastolic blood pressure, The change in diastolic blood pressure from baseline to 4 weeks, 4 weeks|Mean arterial blood pressure, The change in mean arterial blood pressure from baseline to 4 weeks, 4 weeks|Pulse pressure, The change in pulse pressure from baseline to 4 weeks, 4 weeks|Cardiac index, The change from baseline to 4 weeks in cardiac index will be measured using Non-Invasive Cardiac Output Monitoring (Cheetah), 4 weeks | Other: Evolume, The change in extracellular fluid volume from baseline to 4 weeks, measured by multifrequency bioimpedance spectroscopy and normalized to total body weight, 4 weeks
|
